Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Oncology (Williston Park, N.Y.)
|
February 28, 2001
Docetaxel followed by gemcitabine and irinotecan in solid tumors
C M Rocha Lima, J J Urbanic, C A Sherman, et al.
Oncology (Williston Park, N.Y.)
|
April 17, 2001
Irinotecan/gemcitabine combination chemotherapy in pancreatic cancer
C M Rocha Lima, C A Sherman, F J Brescia, et al.
Polymers
|
March 10, 2022
Modelling of Environmental Ageing of Polymers and Polymer Composites-Durability Prediction Methods
Olesja Starkova, Abedin I Gagani, Christian W Karl, et al.
Seminars in Oncology
|
August 18, 2001
Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignancies
C M Rocha Lima, J J Urbanic, A Lal, et al.
ISA Transactions
|
December 15, 2018
Deadbeat-fuzzy controller for the power control of a Doubly Fed Induction Generator based wind power system
C M Rocha-Osorio, J S Solís-Chaves, Lucas L Rodrigues, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 27, 2006
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902
C M Rocha-Lima, J E Herndon, M E Lee, et al.
American Journal of Clinical Oncology
|
February 7, 2007
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma
Robert de W Marsh, C M Rocha Lima, D E Levy, et al.
Polymers
|
January 11, 2022
Modelling of Environmental Ageing of Polymers and Polymer Composites-Modular and Multiscale Methods
Andrey E Krauklis, Christian W Karl, Iuri B C M Rocha, et al.
Oncology (Williston Park, N.Y.)
|
February 24, 2001
Irinotecan in the management of patients with pancreatic cancer
M R Green, M Harper, A Safa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC
C M Rocha Lima, N A Rizvi, C Zhang, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Oncology (Williston Park, N.Y.)
|
February 28, 2001
Docetaxel followed by gemcitabine and irinotecan in solid tumors
C M Rocha Lima, J J Urbanic, C A Sherman, et al.
Oncology (Williston Park, N.Y.)
|
April 17, 2001
Irinotecan/gemcitabine combination chemotherapy in pancreatic cancer
C M Rocha Lima, C A Sherman, F J Brescia, et al.
Polymers
|
March 10, 2022
Modelling of Environmental Ageing of Polymers and Polymer Composites-Durability Prediction Methods
Olesja Starkova, Abedin I Gagani, Christian W Karl, et al.
Seminars in Oncology
|
August 18, 2001
Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignancies
C M Rocha Lima, J J Urbanic, A Lal, et al.
ISA Transactions
|
December 15, 2018
Deadbeat-fuzzy controller for the power control of a Doubly Fed Induction Generator based wind power system
C M Rocha-Osorio, J S Solís-Chaves, Lucas L Rodrigues, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 27, 2006
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902
C M Rocha-Lima, J E Herndon, M E Lee, et al.
American Journal of Clinical Oncology
|
February 7, 2007
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma
Robert de W Marsh, C M Rocha Lima, D E Levy, et al.
Polymers
|
January 11, 2022
Modelling of Environmental Ageing of Polymers and Polymer Composites-Modular and Multiscale Methods
Andrey E Krauklis, Christian W Karl, Iuri B C M Rocha, et al.
Oncology (Williston Park, N.Y.)
|
February 24, 2001
Irinotecan in the management of patients with pancreatic cancer
M R Green, M Harper, A Safa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC
C M Rocha Lima, N A Rizvi, C Zhang, et al.
Page
of 4